Aptiva® Antiphospholipid Syndrome reagents from Werfen receive US FDA 510(k) clearance
Werfen announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Aptiva® Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) Reagents.